In the spirit of modern ‘lifetime management’, consideration should therefore be given as early as the first procedure to which options remain open for subsequent interventions – such as transcatheter aortic valve implantation (TAVI) within...
In the spirit of modern ‘lifetime management’, consideration should therefore be given as early as the first procedure to which options remain open for subsequent interventions – such as transcatheter aortic valve implantation (TAVI) within...
WASHINGTON — Exercise should be prescribed as a foundational component of cardiovascular disease (CVD) prevention and treatment, according to a new American College of Cardiology Scientific Statement published today...
WASHINGTON — Exercise should be prescribed as a foundational component of cardiovascular disease (CVD) prevention and treatment, according to a new American College of Cardiology Scientific Statement published today...
The Paradise™ Ultrasound Renal Denervation (uRDN) system has been recognized by TIME with a Best Inventions of 2026 award in the Medical and Healthcare category.
The Paradise™ Ultrasound Renal Denervation (uRDN) system has been recognized by TIME with a Best Inventions of 2026 award in the Medical and Healthcare category.
MyFit™ by Biogel® is designed to better reflect the diversity of clinicians’ hand anatomy and help more healthcare professionals find a glove that supports comfort, safety and performance – all critical in the operating room.
MyFit™ by Biogel® is designed to better reflect the diversity of clinicians’ hand anatomy and help more healthcare professionals find a glove that supports comfort, safety and performance – all critical in the operating room.
SAN DIEGO -- REVA Medical, LLC announced the successful completion of a live case demonstration featuring the MOTIV® sirolimus-eluting bioresorbable vascular scaffold and the presentation of late-breaking clinical results from the...
SAN DIEGO -- REVA Medical, LLC announced the successful completion of a live case demonstration featuring the MOTIV® sirolimus-eluting bioresorbable vascular scaffold and the presentation of late-breaking clinical results from the...
Operated with Clear Heart and Lung, the unit enables patients in communities without cardiac CT to join Cleerly's TRANSFORM, a trial testing whether treatment guided by coronary artery disease staging prevents heart attacks.
Operated with Clear Heart and Lung, the unit enables patients in communities without cardiac CT to join Cleerly's TRANSFORM, a trial testing whether treatment guided by coronary artery disease staging prevents heart attacks.
Final late-breaking VIVA26 studies reported new data on the Revello™ covered stent for iliac artery disease, Neuroguard IEP carotid stenting outcomes, and early real-world use of the Rotarex™ atherectomy system in CLTI.
Final late-breaking VIVA26 studies reported new data on the Revello™ covered stent for iliac artery disease, Neuroguard IEP carotid stenting outcomes, and early real-world use of the Rotarex™ atherectomy system in CLTI.
Late-breaking VIVA26 studies reported on IVL for calcified PAD, transdermal oxygen therapy after LE revascularization, transcatheter arterialization for no-option CLTI, and DES outcomes in complex femoropopliteal disease.
Late-breaking VIVA26 studies reported on IVL for calcified PAD, transdermal oxygen therapy after LE revascularization, transcatheter arterialization for no-option CLTI, and DES outcomes in complex femoropopliteal disease.
Marios Tsourous, MD; Dimitrios Strepkos, MD; Theodoros Vichos, MD; Michaella Alexandrou, MD; Pedro E.P. Carvalho, MD; Ahmet Akyel, MD; Parth Desai, MD; Ayman Fath, MD; Sophie Macy, BS; James W. Choi, MD; Sevket Gorgulu, MD; Farouc A. Jaffer, MD; Raj Chandwaney, MD; Khaldoon Alaswad, MD; Mir B. Basir, MD; Lorenzo Azzalini, MD, PhD, MSc; Dmitrii Khelimskii, MD; Oleg Krestyaninov, MD; Laura Young, MD; Omer Goktekin, MD; Konstantinos Voudris, MD; Noah N. Williford, MD; Angie S. Lobo, MD; Yader Sandoval, MD; Emmanouil S. Brilakis, MD, PhD
The authors evaluated the clinical characteristics and procedural outcomes of dialysis patients undergoing chronic total occlusion percutaneous coronary intervention in a large, multicenter registry.
The authors evaluated the clinical characteristics and procedural outcomes of dialysis patients undergoing chronic total occlusion percutaneous coronary intervention in a large, multicenter registry.
The authors provide a striking visual demonstration of the anatomical and dynamic mechanisms underlying left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy.
The authors provide a striking visual demonstration of the anatomical and dynamic mechanisms underlying left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy.
James Leung, MBBS; John French, MBChB, PhD; James Xu, MBBS, PhD; Kathryn Wales, MD; Hashim Kachwalla, MBBS; Krishna Kaddapu, MBBS, PhD; Sarah Fares, MPhil; Viet Dang, MBBS; Tamer Badie, MBBS; Christian Mussap, MBBS, PhD; Rohan Rajaratnam, MBBS; Dominic Leung, MBBS, PhD; Sidney Lo, MBBS; Craig Juergens, MBBS, DMedSc
This study compared visual, robotic, and intracoronary imaging lesion length measurements performed during robotic-assisted percutaneous coronary intervention cases enrolled in the PARTY trial.
This study compared visual, robotic, and intracoronary imaging lesion length measurements performed during robotic-assisted percutaneous coronary intervention cases enrolled in the PARTY trial.
Marco Angelillis, MD; Leonardo Misuraca, MD; Paolo Calabria, MD; Cristina Giannini, MD, PhD; Paolo Spontoni, MD; Laura Stazzoni, MD; Alessandro Sticchi, MD, PhD; Giulia Costa, MD, PhD; Marco De Carlo, MD, PhD
The article describes a novel bailout technique illustrated through a clinical case, the SAFE-SEAL (Suture-Assisted Femoral Emergency SEALing) technique, designed to achieve hemostasis following failure of the plug-based component of a hybrid...
The article describes a novel bailout technique illustrated through a clinical case, the SAFE-SEAL (Suture-Assisted Femoral Emergency SEALing) technique, designed to achieve hemostasis following failure of the plug-based component of a hybrid...
A 78-year-old man was admitted with non-ST-segment elevation myocardial infarction. He had a history of ischemic heart disease with prior percutaneous coronary intervention to the right coronary artery and mid-left anterior descending artery.
A 78-year-old man was admitted with non-ST-segment elevation myocardial infarction. He had a history of ischemic heart disease with prior percutaneous coronary intervention to the right coronary artery and mid-left anterior descending artery.
Maedeh Zokaei Nikoo, MD; Rafey Feroze, MD; Luis Augusto Palma Dallan, MD, PhD; Yusef Saeed, MD; Alexander Cove, MD; Abdullah Altorbag, MD; Andreas A. Towers, MD; Syed R. Nabi, MD; Harsh Amin, MD; Sabin Lama, MD; Christopher Mishreky, MD; Kareem Fanous, MD; Justin M. Dunn, MD; Vinicius Esteves, MD; Steven J. Filby, MD
The authors investigated the association between postprocedural antithrombotic regimen and compute tomography-derived device healing following WATCHMAN FLX Pro (Boston Scientific) implantation.
The authors investigated the association between postprocedural antithrombotic regimen and compute tomography-derived device healing following WATCHMAN FLX Pro (Boston Scientific) implantation.
The authors assessed the feasibility, technical considerations, and procedural safety of totally percutaneous transfemoral transcatheter aortic valve replacement via synthetic aortobifemoral bypass grafts.
The authors assessed the feasibility, technical considerations, and procedural safety of totally percutaneous transfemoral transcatheter aortic valve replacement via synthetic aortobifemoral bypass grafts.
A 74-year-old woman with dilated cardiomyopathy, marked left ventricular enlargement, and severe functional mitral regurgitation remained in decompensated heart failure despite dobutamine therapy. Coronary angiography showed no significant...
A 74-year-old woman with dilated cardiomyopathy, marked left ventricular enlargement, and severe functional mitral regurgitation remained in decompensated heart failure despite dobutamine therapy. Coronary angiography showed no significant...